AU Patent

AU2008302345A1 — Method for imaging and treating organs and tissues

Assigned to Oncofluor Inc · Expires 2009-03-26 · 17y expired

What this patent protects

Patent listed against dordaviprone-hydrochloride.

Drugs covered by this patent

dordaviprone-hydrochloride (DORDAVIPRONE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2008302345A1
Jurisdiction: AU
Classification: —
Expires: 2009-03-26
Drug substance claim: No
Drug product claim: No
Assignee: Oncofluor Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.